🎥Hoxton Farms tackles fat, the final frontier for alt meat
“Meat alternatives don’t taste good enough, and it’s the key reason consumers don’t repeat purchase,” claims cultivated fat co Hoxton Farms.
“Meat alternatives don’t taste good enough, and it’s the key reason consumers don’t repeat purchase,” claims cultivated fat co Hoxton Farms.
Green Plains will be able to produce dextrose with significantly lower capital and carbon intensity vs the standard wet milling process, claims the ethanol producer.
Shiru has also developed AI and ML-based models to predict protein expression in microbial systems, helping firms determine the most cost effective way to produce target proteins at scale.
Caladan Bio has developed a lower-cost benchtop bioreactor system designed to enhance data capture and increase experimentation throughput.
According to Olon, it is owed $112m in unpaid manufacturing fees, unreimbursed CapEx, raw materials costs and other costs, plus an estimated $32m in damages resulting from Perfect Day’s alleged fraud.
The Israeli startup leverages AI technology from computational biology specialist Evogene it claims will dramatically speed up the R&D process.
If the marketing of whey from fermentation is too narrowly focused on the ‘animal-free’ aspect, it potentially limits the market, says Netherlands-based startup Vivici.
By producing it in fermentation tanks using microbial strains optimized by Triplebar Bio, FrieslandCampina Ingredients hopes to to unlock new markets for lactoferrin.
Ditch the cell, and use its internal machinery to produce proteins, and you can slash the cost and increase the speed of protein synthesis, says Tierra Biosciences.
For the second year in a row, the sector saw an increase in VC investment despite an overall decline in agrifoodtech funding.
According to the new definition, precision fermentation combines the process of traditional fermentation with the latest advances in biotechnology.
Vivici has been able to move unusually rapidly by leveraging its founders’ expertise in dairy proteins and industrial-scale biomanufacturing, says CEO Stephan van Sint Fiet.
Finless Foods is not commenting on rumors that it is reducing headcount to extend runway, raise capital, and rebuild at a later time.
According to its CEO: “We still have quite a bit of runway as we’ve been very lean. Part of that is because we’ve never invested in large-scale production capacity [in-house] and we’ve never entered the B2C world.”
50,000 petunia plants that glow in the dark are being made available direct to consumers in the US via Light Bio’s website at $29/plant.
But does it make sense to grow a commodity ingredient such as coffee in a bioreactor, or does plant cell culture only make sense for ultra-high-value botanicals such as saffron?
Phytolon aims to launch natural colors produced by genetically engineered baker’s yeast in the US this year, pending regulatory approvals.
Ayana Bio has signed a deal with Wooree Green Science to develop saffron and other bioactives made via plant cell culture.
The capital injection will also help advance work to develop Cavendish bananas engineered to resist the devastating fungal disease Fusarium wilt.
The Israeli startup expects products containing its animal-free whey protein to launch in the US within the year.